P106 The impact of technician-led virtual spirometry sessions on the availability and quality of home spirometry results in a virtual Cystic Fibrosis clinic
{"title":"P106 The impact of technician-led virtual spirometry sessions on the availability and quality of home spirometry results in a virtual Cystic Fibrosis clinic","authors":"C. Long, T. Modzelewski, NJ Bell","doi":"10.1136/thorax-2021-btsabstracts.215","DOIUrl":null,"url":null,"abstract":"IntroductionSpirometry is an essential component of monitoring the health of people with Cystic Fibrosis (CF). Since the Covid-19 pandemic, most consultations have been conducted via video conferencing. All appropriate patients were given MIR Spirobank® portable spirometers (MIR Medical International Research Srl) and asked to send in readings before each clinic. We noticed a fall in the number and quality of spirometry reports available to clinicians in virtual clinics compared to face-to-face reviews. We set out to improve this through a Respiratory Physiologist-led virtual spirometry clinic.MethodsSpirobank® spirometry reports (including grading of quality using ATS/ERS criteria1) provided by patients attending virtual CF clinics in our CF centre in January 2021 were reviewed. Following this review, a virtual spirometry clinic was established (running before the main clinic) in which the patient performs spirometry via the ‘Live Video Exam’ app on their mobile device, coached by a Physiologist who is able to see the patient via their mobile phone camera and view spirometry flow loops in real time, downloading results ready for the subsequent clinic. Review of spirometry available for clinics in May 2021 was then performed and the number and quality of reports available compared.ResultsSpirometry reports were available for 35 out of 70 appointments for patients with Spirobank® devices in January 2021, of which 26/70 (37%) were ATS grade A or B. In May 2021, 50 patients with devices had clinic appointments: 9 provided reports independently (7 grade A or B), 37 were coached by a physiologist (31 A or B), and 4 did not attend or declined a coaching session.ConclusionWithout coaching, only 37% patients with a Spirobank® device provided ATS grade A or B spirometry for virtual CF clinics;this increased to 76% with the introduction of pre-clinic online Respiratory Physiologist coaching sessions.We plan to review how the number and quality of reports provided with and without coaching changes as patient experience in the use of home spirometers increases.ReferenceStandardization of Spirometry 2019 Update. American Journal of Respiratory & Critical Care Medicine 2019;200(8):e70–e88.","PeriodicalId":286165,"journal":{"name":"The wider impact of the pandemic","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The wider impact of the pandemic","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
IntroductionSpirometry is an essential component of monitoring the health of people with Cystic Fibrosis (CF). Since the Covid-19 pandemic, most consultations have been conducted via video conferencing. All appropriate patients were given MIR Spirobank® portable spirometers (MIR Medical International Research Srl) and asked to send in readings before each clinic. We noticed a fall in the number and quality of spirometry reports available to clinicians in virtual clinics compared to face-to-face reviews. We set out to improve this through a Respiratory Physiologist-led virtual spirometry clinic.MethodsSpirobank® spirometry reports (including grading of quality using ATS/ERS criteria1) provided by patients attending virtual CF clinics in our CF centre in January 2021 were reviewed. Following this review, a virtual spirometry clinic was established (running before the main clinic) in which the patient performs spirometry via the ‘Live Video Exam’ app on their mobile device, coached by a Physiologist who is able to see the patient via their mobile phone camera and view spirometry flow loops in real time, downloading results ready for the subsequent clinic. Review of spirometry available for clinics in May 2021 was then performed and the number and quality of reports available compared.ResultsSpirometry reports were available for 35 out of 70 appointments for patients with Spirobank® devices in January 2021, of which 26/70 (37%) were ATS grade A or B. In May 2021, 50 patients with devices had clinic appointments: 9 provided reports independently (7 grade A or B), 37 were coached by a physiologist (31 A or B), and 4 did not attend or declined a coaching session.ConclusionWithout coaching, only 37% patients with a Spirobank® device provided ATS grade A or B spirometry for virtual CF clinics;this increased to 76% with the introduction of pre-clinic online Respiratory Physiologist coaching sessions.We plan to review how the number and quality of reports provided with and without coaching changes as patient experience in the use of home spirometers increases.ReferenceStandardization of Spirometry 2019 Update. American Journal of Respiratory & Critical Care Medicine 2019;200(8):e70–e88.
肺活量测定法是监测囊性纤维化(CF)患者健康的重要组成部分。自新冠肺炎大流行以来,大多数咨询都是通过视频会议进行的。所有合适的患者均给予MIR Spirobank®便携式肺活量计(MIR Medical International Research Srl),并要求在每次就诊前发送读数。我们注意到,与面对面的评估相比,虚拟诊所的临床医生可获得的肺活量测定报告的数量和质量都有所下降。我们开始通过一个由呼吸生理学家领导的虚拟肺活量测定诊所来改善这一点。方法回顾2021年1月在CF中心虚拟CF诊所就诊的患者提供的spirobank®肺活量测定报告(包括使用ATS/ERS标准进行质量分级1)。在此综述之后,建立了一个虚拟肺活量测定诊所(在主诊所之前运行),患者通过移动设备上的“实时视频检查”应用程序进行肺活量测定,由生理学家指导,生理学家能够通过手机摄像头看到患者,实时查看肺活量测定血流循环,并下载结果,为后续诊所做好准备。然后对2021年5月诊所可用的肺活量测定法进行了审查,并比较了可用报告的数量和质量。结果2021年1月,Spirobank®器械患者的70例预约中有35例可获得肺功能报告,其中26/70(37%)为ATS A级或B级。2021年5月,50例器械患者进行了门诊预约:9例独立提供报告(7例为A级或B级),37例由生理学家指导(31例为A级或B级),4例未参加或拒绝指导会议。结论:在没有指导的情况下,只有37%的使用Spirobank®设备的患者在虚拟CF诊所提供ATS a级或B级肺量测量,而在引入临床前在线呼吸生理学家指导课程后,这一比例增加到76%。我们计划回顾随着患者使用家庭肺活量计经验的增加,有无指导的报告数量和质量是如何变化的。参考标准化肺量测定2019更新。中华呼吸与危重症医学杂志2019;2008(8):870 - 888。